Outcome of Board Meeting - The Board of Directors has not recommended any dividend on Equity Shares for the financial year 2025-26.
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemplast Sanmar's Board has not recommended any dividend for FY 2025-26, skipping shareholder reward for the second consecutive year. The company posted consolidated revenue of Rs 4,223.79 Crores (down from Rs 4,346.07 Crores). A massive Rs 898 Crores impairment provision was recorded for subsidiary Chemplast Cuddalore Vinyls (CCVL) due to adverse PVC market conditions including low-priced imports, removal of anti-dumping duty expectations, and raw material volatility. On standalone basis, the company reported a net loss of Rs 882.94 Crores after exceptional items. The Board also appointed Mr V S Radhakrishnan (ex-SBI Deputy MD) as Non-Executive Director and formed a committee of 3 Independent Directors to explore strategic reorganization and M&A opportunities. Statutory auditors gave unmodified opinion on the results.
No dividend for FY 2025-26 is negative for income-focused investors. The Rs 898 Crores impairment signals severe stress in the PVC subsidiary business. Formation of strategic committee suggests potential major corporate changes ahead, which could be value-accretive or risky depending on outcomes.